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Abstract
Background: Abetalipoproteinemia is a rare disorder of fat absorption, characterized by vitamin deficiency, acanthocytosis, and neurologic symptoms including
ataxia and tremor.
Case Report: A 41-year-old male with abetalipoproteinemia is presented. He underwent staged bilateral thalamic deep brain stimulation (DBS) for the treatment
of his tremors. After DBS, the patient achieved significant improvements in his tremors, ataxia, and quality of life.
Discussion: Thalamic DBS proved to be both safe and efficacious in the management of ataxia and tremors in a patient with abetalipoproteinemia. This is the first
report of DBS in abetalipoproteinemia in the literature.
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Introduction
Abetalipoproteinemia or Bassen–Kornzweig syndrome was first
reported by Bassen and Kornzweig1 in 1950, when they observed the
malformation of erythrocytes in a case of retinitis pigmentosa. The
association of this syndrome with hypocholesterolemia was made in
1958 by Jampel and Falls.2 The term abetalipoproteinemia was coined
by Salt et al.3 in 1960, when he noticed the absence of beta-lipoprotein
in the serum of a patient with acanthocytosis and steatorrhea. The
cause of abetalipoproteinemia is attributed to a mutation in the
microsomal triglyceride transfer protein, whose large subunit is found
on chromosome 4q22-24.4,5 This subunit forms a heterodimer with
protein disulfide isomerase, and the complex facilitates the transfer of
lipids onto apolipoprotein B.6,7 The net result of this is the absence of
apolipoprotein B-containing lipoproteins, such as chylomicrons, very-
low-density lipoproteins, and low-density lipoprotein. The absorption
of fat and fat-soluble vitamins is deficient, resulting in vitamin E
deficiency, which leads to many of the neurologic sequelae including
retinal degeneration, hyporeflexia, reduced proprioceptive and
vibratory sense, and ataxia. Tremor, although not a classic feature of
the disease, has also been reported in the literature, but as a rest
tremor.8 We report on a case of a 41-year-old male with
abetalipoproteinemia and a family history of tremors, who underwent
staged bilateral thalamic deep brain stimulation (DBS) for tremors and
ataxia, with significant improvement.
Case report
The patient is a 41-year-old right-handed male who developed a
voice tremor around the age of 15, followed soon thereafter by axial
tremors that impaired his walking, and then bilateral upper extremity
tremors. He had a family history of tremors, including a maternal aunt
and cousin with ‘‘hunchback’’ and tremors of an unspecified type, and
a mother with ‘‘thumb tremors’’. None of the affected family members
was examined, and the nature of the tremors could thus not be
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assessed; however, no family members had a diagnosis of abetalipo-
proteinemia. At age 17, he was diagnosed with abetalipoproteinemia,
based on clinical phenomenology and an extensive work-up; pertinent
findings included a cholesterol of 49 mg/dl (150–300), elevated liver
function tests, and creatine phosphokinase 5 759 U/liter (1–50), 85%
acanthocytes on peripheral smear, 72-hour fecal fat collection on high-
fat diet resulting in diarrhea and 19% dietary fat malabsorbed, vitamin
E level of 1.8 (5.5–18), a mild sensorimotor neuropathy on
electromyography (EMG), and normal amino acid and lysosomal
battery. A written report in the records documented that he was
‘‘homozygous for abetalipoproteinemia’’, but the family was unable to
locate any corroborating genetic report. He was subsequently started
on treatment with vitamin E. His tremors and ataxia, which had
progressed rapidly to that point, stabilized, but left him with significant
disability. EMG and accelerometry recording to assess physiological
properties of the tremor demonstrated a 3–4 Hz tremor of the head
that was alcohol-responsive, and an intention cerebellar tremor of the
extremities not responsive to alcohol. The patient reported mild
tremor relief with alcohol but trials of sodium oxybate (up to 9 mg/
day), propranolol (up to 240 mg/day), gabapentin (900 mg/day), and
clonazepam and primidone (maximum doses not recalled by patient
but both limited by sedation) provided minimal benefit. At the time of
presentation to our center, he was taking sodium oxybate 2.25 q.i.d.,
propranolol 120 mg extended release, and vitamin E. His neurologic
examination was significant for hyporeflexia, diminished distal
vibration and joint position sense, dysmetria on finger–nose testing,
tremulous speech with lack of prosody, a prominent bilateral action
tremor that was present with sustention and in the wing position but
was maximal with finger–nose testing, a ‘‘no–no’’ type head tremor,
and marked axial tremor characterized by oscillatory swaying of the
torso, neck, and head that was particularly disabling upon standing
and severe enough to necessitate a wide base and holding on to walls to
prevent falling. The combination of hand tremors and ataxia was such
that he was unable to hold a cup with one hand without spilling at least
half the contents, and spilled almost the entirety on bringing it to his
mouth. His handwriting was illegible due to a combination of ataxia
and tremor and spirals demonstrated a prominent axis (Figure 1). His
gait was wide-based and affected by the axial tremors with a subtle
dystonic element characterized by turning in of the right leg. Magnetic
resonance imaging (MRI) of the brain with contrast was within normal
limits. Given the atypical nature of the tremors, the prominent ataxia
and the relatively static course since beginning vitamin E, it was felt
that the abetalipoproteinemia was the significant source of his
impairment. After detailed discussions with the patient regarding the
role of thalamic DBS for refractory tremor, the decision was made to
pursue this as a staged procedure, so as to better gauge the degree of
benefit.
The patient underwent left followed by right DBS of the ventral
intermediate (VIM) thalamus, 2 months apart. Since the patient was
right-handed, the left side was done first. A Leksell stereotactic frame
was fixed to the patient’s head, and stereotactic non-contrast computed
tomography (CT) was performed and then fused to a previously
obtained contrast-enhanced MRI scan. The procedure was performed
under local anesthesia, with microelectrode recording, with a
combination of propofol and dexmeditomidine (Precedex) for sedation.
The width of the third ventricle was 2.2 mm and the anterior
commissure–posterior commissure (AC–PC) length was 27.4 mm. The
initial VIM target was set at X 5 11.0 mm lateral to the wall of the
third ventricle, Y 5 25% of the AC–PC length anterior to the PC, and
Z 5 0 (on the AC–PC line). Macrostimulation yielded improvement in
spiral drawing and mild transient facial paresthesias, which led to
implantation with Medtronic model 3387 electrodes slightly ante-
rolateral to the initial target. Postoperative CT imaging fused to the
preoperative MRI scan revealed the location of contact 0 to be
12.3 mm lateral to midline, 7.18 mm (26.4% * AC–PC) posterior to
the midcommissural point, and 1.1 mm below the AC–PC plane. One
week later, the patient underwent implantation of a Medtronic Soletra
pulse generator. Initial programming revealed excellent tremor
control, with the most ventral contact in monopolar stimulation but
the presence of facial paresthesias at higher settings. This eventually
led to employment of a bipolar configuration for optimal tremor
control and tolerability.
At the follow-up visit, the patient reported significant improvements
in his right upper extremity tremor. He was now able to drink and use
a spoon. The head tremor remained unchanged. Given the patient’s
satisfaction, the decision was made to proceed with stimulation on the
right hemisphere. The patient was operated on 2 months later for DBS
of the right VIM, which was performed in a similar fashion to the
contralateral side. Intraoperative macrostimulation at the predeter-
mined target was limited by strong facial paresthesias that were found
to be less prominent on a second, more lateral trajectory. The location
of contact 0 on the right side was 12.3 mm lateral to midline, 6.9 mm
(25% * ACPC) posterior to the midcommissural point, and 0.8 mm
above the ACPC plane. As with the left DBS, initial programming
revealed good tremor reduction with the two most ventral contacts,
but a narrow therapeutic window before facial paresthesias and a
perception of worsening balance emerged. A bipolar configuration
provided good tolerability and tremor reduction.
At 8 months’ follow-up, he demonstrated significant improvement in
bilateral upper extremity tremors. He also experienced improvement
in his axial tremors, although not as dramatic as was seen in the
Figure 1. Spiral Drawings Before and After Initial Programming.
Spiral drawings before (A) and after (B) initial programming, demonstrating
improvement in tremor with stimulation.
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extremities. His gait, which had transiently worsened post-operatively,
stabilized, and improved somewhat compared with baseline, as was
also evidenced by comparing his ON vs. OFF-stimulation examination
(see Video 1). The pre- and post-stimulation video was analyzed by a
movement disorder specialist not involved with the case and blinded to
stimulator status in regards to the clinical efficacy of stimulation. These
assessments were made using the essential tremor rating assessment
scale (TETRAS), rating head, right upper extremity, left upper
extremity, standing and spiral (scored 1–4, with 1 being least severe),
and the brief ataxia rating scale (BARS), scoring gait (scored 0–8, with
0 being normal), and left and right finger-to-nose (scored 0–4, with 0
being normal). These results are summarized in Table 1.
He was weaned off sodium oxybate and reduced his propranolol
dose by one-third. His stimulator settings were as follows: Left: 3+0-1-
2-, 3.6 V, 90 ms, 145 Hz; Right: 3+0-1-2-, 3.6 V, 90 ms, 135 Hz.
Discussion
Thalamic DBS is a well-established modality for the treatment of
refractory tremor and is currently approved for treatment of essential
tremor and Parkinson’s disease. Targeting the VIM thalamus for many
different tremor types has been extensively reviewed in the literature.9–11
We are not aware, however, of any previously reported cases of DBS
in the treatment of tremor associated with abetalipoproteinemia.
In this report, we present the case of a patient with a history of
abetalipoproteinemia whose presenting symptom was axial and
appendicular action tremor. The patient responded well to stimula-
tion, with marked improvement of the appendicular component of the
tremors, and moderate but appreciable improvement of the axial
symptoms following bilateral VIM stimulation. Interestingly, rather
high settings using multiple contacts were required. These settings
could reflect the need to compensate for paresthesias found using
monopolar stimulation. It is also possible, however, that more medial
stimulation (as suggested by the presence of facial paresthesias) was a
factor contributing to improvement of the midline tremors. We further
hypothesize that the extensively involved somatotopy (axial and
appendicular) required a wider field of stimulation. Given the
unblinded nature of the report, the possibility of a placebo component
cannot be excluded, but the dramatic improvement beyond 6 months
and immediate return of symptom severity off stimulation noted on
numerous assessments argues against this being a prominent confound.
Evaluation of a pre- and post-stimulation video performed by a
movement disorder specialist not involved in the case and blinded to
stimulator status also supports the clinical efficacy of the intervention
(Table 1).
Bilateral DBS of the VIM thalamus can be effective in the treatment
of tremors associated with abetalipoproteinemia and should be
considered in cases refractory to medications. This is the only report
of DBS being used in abetalipoproteinemia. Further experience is
necessary, but these results encourage consideration of DBS even when
there is a component of concomitant ataxia.
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Right upper extremity 3 2




Right finger–nose 3 1
Left finger–nose 4 1
Gait 4 2
Abbreviations: BARS, brief ataxia rating scale; DBS, deep brain
stimulation; TETRAS, The Essential Tremor Rating Assessment Scale.
Video 1.
Video Segment 1. Post-Operative Video of the Patient with
Stimulation Off and Then On. In a state of ‘‘OFF’’ stimulation there are
significant extremity and axial tremors. With the stimulator ‘‘ON’’, there are
significant improvement in both the extremity and axial tremors, as well as gait.
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